Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » CareDx Accuses Natera of False Advertising in Second Lawsuit

CareDx Accuses Natera of False Advertising in Second Lawsuit

Apr 10, 2019
|
staff reporter

This article has been updated to include a statement from Natera.

NEW YORK (GenomeWeb) – CareDx has filed a second lawsuit against Natera today in the United States District Court for Delaware, accusing the company of trying to "mislead" patients and clinicians into thinking that Natera's Prospera kidney transplant test is superior to CareDx's AlloSure organ transplant diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

What's Popular?

In Business News

  1. WuXi Diagnostics Closes $150M Series B Financing Round

  2. UPDATE: Meridian Withdraws Emergency Use Authorization Application to FDA for Coronavirus MDx Test

  3. Progenity Enters $25M Private Placement

  4. DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick

  5. Myriad Genetics Quarterly Revenues Decline 21 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.